Page last updated: 2024-09-05

cilengitide and EHS Tumor

cilengitide has been researched along with EHS Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Bruijn, EA; de Wiel-Ambagtsheer, Ga; Eggermont, AM; Goodman, SL; Grell, M; Meyring, M; Ruegg, C; Seynhaeve, AL; Ten Hagen, TL; van Tiel, ST	1

Other Studies

1 other study(ies) available for cilengitide and EHS Tumor

Article	Year
The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model. International journal of cancer, 2013, Jun-01, Volume: 132, Issue:11 Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Disease Models, Animal; Drug Synergism; Limb Salvage; Male; Melphalan; Rats; Rats, Inbred BN; Receptors, Vitronectin; Sarcoma, Experimental; Snake Venoms	2013

Article

Year

The αVβ3/αVβ5 integrin inhibitor cilengitide augments tumor response to melphalan isolated limb perfusion in a sarcoma model.

International journal of cancer, 2013, Jun-01, Volume: 132, Issue:11

Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Disease Models, Animal; Drug Synergism; Limb Salvage; Male; Melphalan; Rats; Rats, Inbred BN; Receptors, Vitronectin; Sarcoma, Experimental; Snake Venoms

2013